Fundraising Fox
Corcept Therapeutics
NASDAQ: CORTIncorporated in Delaware · 3 known investors
Find your way into Corcept Therapeutics
Sign up to see every warm intro you have to Corcept Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Corcept Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Corcept develops cortisol modulators — molecules that regulate cortisol activity at the glucocorticoid receptor — to treat serious diseases across endocrinology, oncology, metabolism, and neurology. Its FDA-approved drug Korlym (mifepristone) treats hypercortisolism (Cushing syndrome), and the company has over 30 ongoing studies and more than 1,000 discovered proprietary cortisol modulators.
Founders & leadership
JK
Joseph K. BelanoffChief Executive Officer and President
Investors · 3
Founder mafia
2 people who came through Corcept Therapeutics went on to found or lead other companies.
Related companies · 5
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
TipRanksFinancial analysis and stock research platform.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Companies working in the same space as Corcept Therapeutics.
Frequently asked questions
- What does Corcept Therapeutics do?
- Corcept develops cortisol modulators — molecules that regulate cortisol activity at the glucocorticoid receptor — to treat serious diseases across endocrinology, oncology, metabolism, and neurology. Its FDA-approved drug Korlym (mifepristone) treats hypercortisolism (Cushing syndrome), and the company has over 30 ongoing studies and more than 1,000 discovered proprietary cortisol modulators.
- Who founded Corcept Therapeutics?
- Corcept Therapeutics was founded by Joseph K. Belanoff.
- Who are Corcept Therapeutics's investors?
- Corcept Therapeutics's investors include Longitude Capital, Mountain Group Capital, Ridgeback Capital.